Longevity Biotech
0 followers
‌
Longevity Biotech is developing a new class of therapeutic candidates called Hybridtides. Their focus is on delivering clinically transformative products that tackle the most challenging aspects of medicine today.
Industries
Headquarters
Employees
Links
Org chart
Scott Shandler
Founder & CEO
